Pluri Inc. — Director's Dealing 2020

Jul 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2020-07-28

Reporting Person: CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-28	Common Stock	P	81198	$8.46	Acquired	3542040	Direct

Footnotes

F1: The reported price in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from approximately $8.40 to $8.52 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.